ArticleCells2026

1D228 Attenuates Sorafenib Resistance in Renal Cell Carcinoma Models by Dual Targeting c-Met and AXL.

Hanxu Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.